Page last updated: 2024-08-26

cb 10375 and Lung Neoplasms

cb 10375 has been researched along with Lung Neoplasms in 1 studies

*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abel, G; Coley, HM; Jarman, M; Judson, IR; Rutty, CJ; Thornton, TJ; Wilman, DE	1

Other Studies

1 other study(ies) available for cb 10375 and Lung Neoplasms

Article	Year
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl. Journal of medicinal chemistry, 1993, Dec-24, Volume: 36, Issue:26 Topics: Animals; Antineoplastic Agents; Drug Stability; Half-Life; Humans; Hydrogen-Ion Concentration; Hydrolysis; Leukemia L1210; Lung Neoplasms; Molecular Structure; Plasmacytoma; Rats; Solubility; Structure-Activity Relationship; Triazines; Tumor Cells, Cultured	1993

Article

Year

Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl.

Journal of medicinal chemistry, 1993, Dec-24, Volume: 36, Issue:26

Topics: Animals; Antineoplastic Agents; Drug Stability; Half-Life; Humans; Hydrogen-Ion Concentration; Hydrolysis; Leukemia L1210; Lung Neoplasms; Molecular Structure; Plasmacytoma; Rats; Solubility; Structure-Activity Relationship; Triazines; Tumor Cells, Cultured

1993